The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.
about
RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonistVitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotypeDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsHigh density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskWhat does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport?From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportProteomics investigations of HDL: challenges and promiseMolecular mechanisms of cellular cholesterol effluxHigh-Density Lipoprotein Processing and Premature Cardiovascular DiseaseMicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasisHDL-apoA-I exchange: rapid detection and association with atherosclerosisNovel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In VitroEnhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetesSerum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophagesThe effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular diseaseDalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeysReduced HDL function in children and young adults with type 1 diabetes.Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Anti-psoriatic therapy recovers high-density lipoprotein composition and function.Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality.Myeloperoxidase, inflammation, and dysfunctional high-density lipoproteinCholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.Health effects of olive oil polyphenols: recent advances and possibilities for the use of health claims.Evidence that chromium modulates cellular cholesterol homeostasis and ABCA1 functionality impaired by hyperinsulinemia--brief report.HDL cholesterol efflux capacity and incident cardiovascular events.Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular riskEffect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHAHepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in miceSmall HDL promotes cholesterol efflux by the ABCA1 pathway in macrophages: implications for therapies targeted to HDL.A mathematical model of atherosclerosis with reverse cholesterol transport and associated risk factors.Impact of self-association on function of apolipoprotein A-IRobust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoproteinInhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.High-density lipoprotein heterogeneity and function in reverse cholesterol transport.A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol
P2860
Q21132391-A756E36F-8035-4317-9812-8736DD5005D3Q24634553-F2CB0059-C69C-4FD7-9899-80A69998642BQ26774903-5692F985-3CEA-45FD-99B3-0EBDAF796AB4Q26775420-39560B4B-88A4-44BE-95F9-89B30A841714Q26821862-A1C86518-F61A-4FBD-B55D-C56451FA6F92Q26997647-4D6C5155-1F2E-4B2F-856D-376DC4A9A1FDQ27000995-29A934B3-84D6-490C-8298-11BF031DD479Q27021139-16DF9BB4-EBEC-4F9C-988E-7D657E8F5E01Q28085143-8E447CCD-6851-40E8-83DE-0317DC403E8CQ28509140-682F8F93-ADC0-46A8-98EE-FD9A3F90834CQ28535779-43C4EB0C-8F64-42CA-8630-9EAC7628030FQ28546760-BD53FC06-CEA8-441E-99F6-04DBF5F19C1BQ33582205-6D3B6E7C-27F3-4646-87B0-94D8BB826EDFQ33669547-08815591-7D49-4B7C-9E7E-5AFFE9225CC0Q33771752-B7DAFE60-1ACB-4D9B-9097-189B40BB6BEFQ33825419-3A929FAF-3FB0-4ADA-B3E0-1A6FE562A734Q33855092-609F11AB-34FE-4923-B7C2-66E0AC663343Q33867662-0747F8B2-D8A2-4385-A360-E3F222DB9CABQ33882594-5981C197-E213-4ACA-AECC-C3BA9450C002Q33940012-2DF4A9FB-32A0-49A3-8EAB-F5E99C10EB83Q34119124-D3C29E0A-BF9A-4BA7-941D-3CC1CB738C5EQ34155049-F22FC834-C012-46E9-A803-749BCFBC854EQ34259215-DDE9D02A-EECC-4A8B-9560-3521AD0885DBQ34263443-091473EA-D01B-46BD-B408-A73A3D465D7DQ34291776-F4E5E984-0085-4B36-AE8F-32C17DBC4E9BQ34537191-9A0D6295-EEDF-40E6-BD0F-D921178F23A1Q34562290-13EBD335-7173-4F71-A53F-1657957E0796Q34602100-6CCB113B-935B-43B8-A0C4-B26906D47988Q34842747-7063B8C2-52C3-4037-A65A-993304E97835Q35021594-10C6EE38-045D-440F-BB26-F973FE0835C0Q35107313-5A760B54-EDF3-4FBF-8E3E-FE35C1D45A55Q35120961-6E692FD1-C7EE-49B2-AF40-22F602503FFAQ35138400-98CC2CB8-278E-4354-88DC-BF29DEE25D94Q35234656-635411E7-3D34-4F6D-82F4-CFE9EC89DE6FQ35245132-2751664A-0494-41CA-9705-EA420E32EF8DQ35371440-82D34B89-DE94-404B-9CE9-52FAA9B00D5DQ35536400-9028DDE0-C50A-4964-B015-FC948AC60DFBQ35536404-B936DA8F-7468-4502-9B1B-4CD832BA51A5Q35546972-F189E9F2-0AA4-4EC5-9A39-77F210AE5E49Q35561997-F4DF4FF4-8345-4406-884B-2AE4F865E7DC
P2860
The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The ability to promote efflux ...... cholesterol from macrophages.
@ast
The ability to promote efflux ...... cholesterol from macrophages.
@en
type
label
The ability to promote efflux ...... cholesterol from macrophages.
@ast
The ability to promote efflux ...... cholesterol from macrophages.
@en
prefLabel
The ability to promote efflux ...... cholesterol from macrophages.
@ast
The ability to promote efflux ...... cholesterol from macrophages.
@en
P2093
P2860
P921
P1476
The ability to promote efflux ...... cholesterol from macrophages.
@en
P2093
Bela F Asztalos
Daniel J Rader
Denise Drazul-Schrader
George H Rothblat
Margarita de la Llera-Moya
Marina Cuchel
P2860
P304
P356
10.1161/ATVBAHA.109.199158
P407
P577
2010-01-14T00:00:00Z